Pay in 4 interest-free payments of $6.56 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
10.1039/D2MO00124A 87 JasonL
This will be a retrospective patient health record study, examining diabetes and obesity patients who received a GLP-1 and their subsequent rates of opioid overdose and other health outcomes
00226-8/asset/6fb2a82a-3829-4742-96c8-70e9d464ea34/main.assets/gr2.jpg)
MiaoHWangYNYuXYZouLGuoYSuWet al
In addition, because the tissues in which the GLP-1 receptor is expressed are not limited to the gastrointestinal and pancreatic glands, GLP-1RA can reduce cardiovascular risk in addition to lowering glucose and reducing body weight
Muhammad, A
00213-0/asset/3bf08982-433a-4e78-933c-d49e6ac25024/main.assets/gr1_lrg.jpg)
In comparison to the control, growth of MRAB isolates in presence of amikacin were significantly reduced from 6 g/ml amikacin for MRAB-1 and -2, and from 8 and 10 g/ml amikacin for MRAB-3 and -4, respectively (B)
US$ 27.44
US$ 25.08
US$ 29.77
US$ 20.93
